Cessation of Mr. Apurva S. Diwanji (DIN: 00032072) as the Director (including as the Independent Director) effective from Tuesday, May 12, 2026, consequent upon completion of his tenure.
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences Limited announced that Mr. Apurva S. Diwanji (DIN: 00032072) has ceased as Director and Independent Director effective May 12, 2026, upon completion of his tenure. This is a planned, routine cessation rather than a sudden departure. The company placed on record its sincere appreciation for Mr. Diwanji's valuable contributions, dedication, integrity, and professional expertise during his tenure. The disclosure was made to BSE and NSE under Regulation 30 of the SEBI Listing Regulations.
This is a standard board-level change at the end of a pre-defined tenure with no indication of governance concerns or disagreements, and is unlikely to have any material impact on the company's operations or stock price.